Detalhe da pesquisa
1.
Structural Lung Disease and Clinical Phenotype in Bronchiectasis Patients: The EMBARC CT Study.
Am J Respir Crit Care Med
; 2024 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38635862
2.
The Association Between Bronchiectasis and Chronic Obstructive Pulmonary Disease: Data from the European Bronchiectasis Registry (EMBARC).
Am J Respir Crit Care Med
; 2024 Jan 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38271696
3.
Bronchiectasis and asthma: Data from the European Bronchiectasis Registry (EMBARC).
J Allergy Clin Immunol
; 2024 Feb 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38401857
4.
Reversal of cylindrical bronchial dilatations in a subset of adults with cystic fibrosis treated with elexacaftor-tezacaftor-ivacaftor.
Eur Respir J
; 2024 Feb 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38331460
5.
Airway clearance management in people with bronchiectasis: data from the European Bronchiectasis Registry (EMBARC).
Eur Respir J
; 2024 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38609097
6.
Objective sputum colour assessment and clinical outcomes in bronchiectasis: data from the European Bronchiectasis Registry (EMBARC).
Eur Respir J
; 63(4)2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38609095
7.
Pulmonary and Nonpulmonary Sepsis Differentially Modulate Lung Immunity toward Secondary Bacterial Pneumonia: A Critical Role for Alveolar Macrophages.
Am J Respir Cell Mol Biol
; 68(6): 689-701, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36883953
8.
Beyond borders: cystic fibrosis survival between Australia, Canada, France and New Zealand.
Thorax
; 78(3): 242-248, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36109163
9.
Infections in autoimmune pulmonary alveolar proteinosis: a large retrospective cohort.
Thorax
; 79(1): 68-74, 2023 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37758458
10.
The French Compassionate Program of elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis with advanced lung disease and no F508del CFTR variant.
Eur Respir J
; 2023 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36796836
11.
Theratyping cystic fibrosis patients to guide elexacaftor/tezacaftor/ivacaftor out-of-label prescription.
Eur Respir J
; 62(4)2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37696564
12.
CFTR Modulators: Current Status and Evolving Knowledge.
Semin Respir Crit Care Med
; 44(2): 186-195, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36535667
13.
Cumulative Incidence and Risk Factors for Severe Coronavirus Disease 2019 in French People With Cystic Fibrosis.
Clin Infect Dis
; 75(12): 2135-2144, 2022 12 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35475917
14.
Impact of a high emergency lung transplantation programme for cystic fibrosis in France: insight from a comparison with Canada.
Eur Respir J
; 59(1)2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34140297
15.
Arpin is critical for phagocytosis in macrophages and is targeted by human rhinovirus.
EMBO Rep
; 21(1): e47963, 2020 01 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31721415
16.
Rapid Improvement after Starting Elexacaftor-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and Advanced Pulmonary Disease.
Am J Respir Crit Care Med
; 204(1): 64-73, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33600738
17.
Effective control of Staphylococcus aureus lung infection despite tertiary lymphoid structure disorganisation.
Eur Respir J
; 57(4)2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33093122
18.
Using chest CT scan and unsupervised machine learning for predicting and evaluating response to lumacaftor-ivacaftor in people with cystic fibrosis.
Eur Respir J
; 2021 Nov 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34795038
19.
Involvement of CFTR in the pathogenesis of pulmonary arterial hypertension.
Eur Respir J
; 58(5)2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33926975
20.
Topological data analysis reveals genotype-phenotype relationships in primary ciliary dyskinesia.
Eur Respir J
; 58(2)2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33479112